Matthias Stephan, M.D., Ph.D.

faculty member

Matthias Stephan, M.D., Ph.D.

Associate Member, Program in Immunology
Clinical Research Division, Fred Hutch

Fax: 206.667.7983
Mailstop: D3-100

Dr. Matthias Stephan is an expert in immunobioengineering, a discipline that marries innovative materials engineering with strategies for improving immune-based therapies. He and his team are developing new approaches involving “smart” synthetic materials to boost the body’s natural ability to fight cancer. He developed a biodegradable sponge-like scaffold that can be loaded with cancer-fighting immune cells and immune-boosting drugs, then surgically implanted to help prevent disease recurrence or treat a tumor that cannot be safely removed. With Fred Hutch colleagues, Dr. Stephan is now developing and testing scaffolds to treat breast, ovarian, pancreatic and brain cancers. He is also developing nanoparticles to improve the curative power of an immunotherapy called T-cell therapy. For example, he is crafting nanoparticles to deliver molecules that would prime tumors for the therapy by shutting down their ability to evade or block the incoming T-cells.

Other Appointments & Affiliations

Associate Professor, Oncology
University of Washington School of Medicine

Adjunct Assistant Professor, Bioengineering
University of Washington

Allen Distinguished Investigator
The Paul G. Allen Frontiers Group

Education

M.D., Medical University of Luebeck, Germany, 2002

Clinical Fellowship, Imperial College, London, United Kingdom, 2000

Ph.D., Cornell University, 2008

Postdoctoral Training, Massachusetts Institute of Technology, 2008-2012

Find A Clinical Trial

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email media@fredhutch.org or call 206.667.2210